Lemaitre Vascular (LMAT) Accounts Payables (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Accounts Payables data on file, last reported at $4.2 million in Q1 2026.

• Accounts Payables for Q1 2026 came in at $4.2 million, up 91.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (up 91.66% YoY), and the FY2025 annual result was $3.6 million, up 107.04% from the prior year.
• Accounts Payables improved to $4.2 million in Q1 2026 per LMAT's latest filing, from $3.6 million in the prior quarter.
• Over five years, Accounts Payables peaked at $4.9 million in Q2 2025 and troughed at $1.7 million in Q3 2024.
• A 5-year average of $3.1 million and a median of $3.1 million in 2024 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2024 and 2025: Accounts Payables slumped 62.23% in 2024, then surged 146.32% in 2025.
• A 5-year view of Accounts Payables shows it stood at $2.9 million in 2022, then increased by 28.63% to $3.7 million in 2023, then plunged by 52.84% to $1.8 million in 2024, then jumped by 107.04% to $3.6 million in 2025, then rose by 14.65% to $4.2 million in 2026.
• Business Quant data shows LMAT's Accounts Payables at $4.2 million in Q1 2026, $3.6 million in Q4 2025, and $3.5 million in Q3 2025.